NOsocomial Dissemination Risk of SARS-Cov2

Study Overview
=================
Brief Summary
-----------------
To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing. Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2. This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community

Detailed Description
-----------------
It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days . At each staff rotation, an individualsensorwill be provided toall thestaff(caregivers, administrative, students etc…) to be worn duringtheirworking hours. Also a sensor will be placed at each patient's bedside. In addition, epidemiological data relating to socio-demographic characteristics, profession, protective measures will be collectedfrom hospitalstaff. Also, some data from the 'entrepot des données de santé regarding individual carepathways in the hospitalwill be extracted. A map of the unit, specifying the location of each patient will be made.

Official Title
-----------------
NOsocomial Dissemination Risk of SARS-Cov2

Conditions
-----------------
Sars-CoV2

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria for patients: Informed of the purpose of the study and having expressed his non-opposition or of a relative (if the patient's state of health does not allow it) Hospitalized in one of the participating departments Inclusion criteria for hospital staff: Informed of the objective of the study and having expressed his no opposition Having daily contact with patients hospitalized in participating departments Inclusion criteria for patient visitors Informed of the purpose of the study and having expressed his non-opposition Having daily contacts with patients hospitalized in the participating departments Exclusion Criteria for evryone (patient, hospital staff and patients visitors) : Refuse to participate
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Understanding the dissemination of SARS Cov2 in hospital | In each unit, during 2 days, Patients and all staff (caregivers, administrative, students…) will carry an individualsensorwhich will regularly measure the proximity between 2 sensors | 2 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Optimizing hospital strategies to prevent transmission to caregivers and not infected hospitalized patients with SARSCov2 |  | 8 weeks |